135 related articles for article (PubMed ID: 10469901)
21. The effect of wet granulation on the erosion behaviour of an HPMC-lactose tablet, used as a rate-controlling component in a pulsatile drug delivery capsule formulation.
McConville JT; Ross AC; Chambers AR; Smith G; Florence AJ; Stevens HN
Eur J Pharm Biopharm; 2004 May; 57(3):541-9. PubMed ID: 15093604
[TBL] [Abstract][Full Text] [Related]
22. [Preparation and in vitro release of tetramethylpyrazine phosphate pulsincap capsule controlled by an erodible plug].
Wu F; Zhang ZR; He WL; Zhang Y
Yao Xue Xue Bao; 2002 Sep; 37(9):733-8. PubMed ID: 12567902
[TBL] [Abstract][Full Text] [Related]
23. Correlation between the viscoelastic properties of the gel layer of swollen HPMC matrix tablets and their in vitro drug release.
Hamed R; Al Baraghthi T; Sunoqrot S
Pharm Dev Technol; 2018 Nov; 23(9):838-848. PubMed ID: 27808590
[TBL] [Abstract][Full Text] [Related]
24. Different HPMC viscosity grades as coating agents for an oral time and/or site-controlled delivery system: a study on process parameters and in vitro performances.
Sangalli ME; Maroni A; Foppoli A; Zema L; Giordano F; Gazzaniga A
Eur J Pharm Sci; 2004 Aug; 22(5):469-76. PubMed ID: 15265517
[TBL] [Abstract][Full Text] [Related]
25. Optimisation of floating matrix tablets and evaluation of their gastric residence time.
Baumgartner S; Kristl J; Vrecer F; Vodopivec P; Zorko B
Int J Pharm; 2000 Feb; 195(1-2):125-35. PubMed ID: 10675690
[TBL] [Abstract][Full Text] [Related]
26. Effect of FITC-dextran molecular weight on its release from floating cetyl alcohol and HPMC tablets.
Xu G; Groves MJ
J Pharm Pharmacol; 2001 Jan; 53(1):49-56. PubMed ID: 11206192
[TBL] [Abstract][Full Text] [Related]
27. Calculation of the required size and shape of hydroxypropyl methylcellulose matrices to achieve desired drug release profiles.
Siepmann J; Kranz H; Peppas NA; Bodmeier R
Int J Pharm; 2000 May; 201(2):151-64. PubMed ID: 10878322
[TBL] [Abstract][Full Text] [Related]
28. In vitro evaluation of pectin-HPMC compression coated 5-aminosalicylic acid tablets for colonic delivery.
Turkoglu M; Ugurlu T
Eur J Pharm Biopharm; 2002 Jan; 53(1):65-73. PubMed ID: 11777754
[TBL] [Abstract][Full Text] [Related]
29. Release characteristics and in vitro-in vivo correlation of pulsatile pattern for a pulsatile drug delivery system activated by membrane rupture via osmotic pressure and swelling.
Lin HL; Lin SY; Lin YK; Ho HO; Lo YW; Sheu MT
Eur J Pharm Biopharm; 2008 Sep; 70(1):289-301. PubMed ID: 18539015
[TBL] [Abstract][Full Text] [Related]
30. Release of theophylline and carbamazepine from matrix tablets--consequences of HPMC chemical heterogeneity.
Viridén A; Abrahmsén-Alami S; Wittgren B; Larsson A
Eur J Pharm Biopharm; 2011 Aug; 78(3):470-9. PubMed ID: 21316446
[TBL] [Abstract][Full Text] [Related]
31. Formulation, release characteristics and bioavailability of novel monolithic hydroxypropylmethylcellulose matrix tablets containing acetaminophen.
Cao QR; Choi YW; Cui JH; Lee BJ
J Control Release; 2005 Nov; 108(2-3):351-61. PubMed ID: 16154656
[TBL] [Abstract][Full Text] [Related]
32. Application of binary polymer system in drug release rate modulation. 2. Influence of formulation variables and hydrodynamic conditions on release kinetics.
Kim H; Fassihi R
J Pharm Sci; 1997 Mar; 86(3):323-8. PubMed ID: 9050800
[TBL] [Abstract][Full Text] [Related]
33. [Preparation of diltiazem hydrochloride delayed-onset, sustained release tablet].
Zhang N; Zhu JB
Yao Xue Xue Bao; 2002 Sep; 37(9):724-7. PubMed ID: 12567900
[TBL] [Abstract][Full Text] [Related]
34. Selective drug delivery to the colon using pectin:chitosan:hydroxypropyl methylcellulose film coated tablets.
Macleod GS; Fell JT; Collett JH; Sharma HL; Smith AM
Int J Pharm; 1999 Oct; 187(2):251-7. PubMed ID: 10502631
[TBL] [Abstract][Full Text] [Related]
35. Release behavior and photo-image of nifedipine tablet coated with high viscosity grade hydroxypropylmethylcellulose: effect of coating conditions.
Cao QR; Choi HG; Kim DC; Lee BJ
Int J Pharm; 2004 Apr; 274(1-2):107-17. PubMed ID: 15072787
[TBL] [Abstract][Full Text] [Related]
36. Synchronized release of sulpiride and sodium decanoate from HPMC matrices: a rational approach to enhance sulpiride absorption in the rat intestine.
Baluom M; Friedman M; Assaf P; Haj-Yehia AI; Rubinstein A
Pharm Res; 2000 Sep; 17(9):1071-6. PubMed ID: 11087038
[TBL] [Abstract][Full Text] [Related]
37. Once-daily propranolol extended-release tablet dosage form: formulation design and in vitro/in vivo investigation.
Huang YB; Tsai YH; Yang WC; Chang JS; Wu PC; Takayama K
Eur J Pharm Biopharm; 2004 Nov; 58(3):607-14. PubMed ID: 15451535
[TBL] [Abstract][Full Text] [Related]
38. Drug release behavior of polymeric matrix filled in capsule.
Phaechamud T; Darunkaisorn W
Saudi Pharm J; 2016 Nov; 24(6):627-634. PubMed ID: 27829804
[TBL] [Abstract][Full Text] [Related]
39. High molecular weight polyethylene oxides (PEOs) as an alternative to HPMC in controlled release dosage forms.
Maggi L; Bruni R; Conte U
Int J Pharm; 2000 Feb; 195(1-2):229-38. PubMed ID: 10675700
[TBL] [Abstract][Full Text] [Related]
40. A new drug delivery system using plasma-irradiated pharmaceutical aids. IX. Controlled-release of theophylline from double-compressed tablet composed of cellulose derivatives as wall material.
Ito K; Kondo S; Kuzuya M
Chem Pharm Bull (Tokyo); 2001 Dec; 49(12):1615-20. PubMed ID: 11767083
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
